Julie Gerberding

Julie Gerberding

Director/Board Member chez HILLEVAX, INC.

Fortune : 698 876 $ au 31/03/2024

69 ans
Health Technology
Commercial Services
Health Services

Profil

Julie Louise Gerberding is currently the President, Chief Executive Officer & Director at the Foundation for the National Institutes of Health, Inc. She is also a Director at the Biotechnology Innovation Organization, Accordia Global Health Foundation, MSD Wellcome Trust Hilleman Laboratories Pvt Ltd., SummerBio LLC, Afternext Healthtech Acquisition Corp., HilleVax, Inc., and a Trustee at Case Western Reserve University and Mayo Clinic.
Additionally, she is a Member of the National Academy of Public Administration and the National Academy of Medicine (United States).
In her former positions, Dr. Gerberding served as the Co-Chairman at MSD Vaccines Ltd.
She was an Independent Director at Cerner Corp.
from 2017 to 2022.
From 1998 to 2009, she worked at the Centers for Disease Control & Prevention, where she served as the Director from 2002 to 2009.
She was also a Director at Project HOPE-The-People-To-People Health Foundation, Inc. and Executive Vice President-Strategic Communications at Merck & Co., Inc. from 2015 to 2016.
Additionally, she was the President of Merck Vaccine Division from 2010 to 2014.
Dr. Gerberding received her undergraduate and doctorate degrees from Case Western Reserve University.
She also holds a graduate degree from the University of California, Berkeley, which she obtained in 1990.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
07/06/2023 42 025 ( 0,08% ) 698 876 $ 31/03/2024

Postes actifs de Julie Gerberding

SociétésPosteDébut
AFTERNEXT HEALTHTECH ACQUISITION CORP. Director/Board Member 16/08/2021
HILLEVAX, INC. Director/Board Member 01/04/2021
Director/Board Member 16/03/2022
Corporate Officer/Principal -
Chief Executive Officer 16/05/2022
Director/Board Member 01/01/2010
Director/Board Member -
Director/Board Member -
Corporate Officer/Principal -
░░░░░░░░ ░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Tous les postes actifs de Julie Gerberding

Anciens postes connus de Julie Gerberding

SociétésPosteFin
░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░ ░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ -
Voir l'expérience en détail de Julie Gerberding

Formation de Julie Gerberding

Case Western Reserve University Doctorate Degree
University of California, Berkeley Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Julie Gerberding

Relations

100 +

Relations au 1er degré

18

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
MERCK & CO., INC.

Health Technology

AFTERNEXT HEALTHTECH ACQUISITION CORP.

Finance

HILLEVAX, INC.

Health Technology

Entreprise privées13

Technology Services

Commercial Services

Health Services

Government

Health Technology

Commercial Services

Health Services

Commercial Services

Commercial Services

Accordia Global Health Foundation

Miscellaneous

Merck Vaccine Division

Health Technology

Health Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Julie Gerberding